Suicide

Researchers have used an algorithmic approach to confirm well-known risk factors for suicide attempt and identify new ones, according to study results published in JAMA Psychiatry.

Hydroxychloroquine as a treatment for rheumatoid arthritis does not appear to increase the risk for depression, suicide, suicidal ideation or psychosis, compared with sulfasalazine, according to data published in Rheumatology.

A machine learning model may significantly reduce the error for annual suicide rate estimation, according to results of a cross-sectional national study published in JAMA Network Open.

Gay, lesbian and bisexual veterans were at increased risk for suicide mortality, according to results of a retrospective population-based cohort study published in JAMA Network Open.

Individuals with Parkinson’s disease were at increased risk for suicide, according to results of a nationwide population-based cohort study published in JAMA Psychiatry.

Significant suicidality and adverse psychological events were reported in subjects who used finasteride to treat alopecia, according to a study published in JAMA Dermatology.

Men whose job expectations were unmet due to labor market declines were at increased risk for death from suicide or drug poisoning vs. men with different job expectations, according to study results published in JAMA Network Open.

Healio Psychiatry has compiled a list of its five most-viewed stories in November.

Suicide rates did not appear to increase after COVID-19 lockdown in a region with a relatively low number of COVID-19 cases, according to results of an interrupted time series analysis published in The Lancet Psychiatry.

The American Foundation for Suicide Prevention designated Nov. 21 as International Survivors of Suicide Loss Day, meant to highlight family and friends of those who have died by suicide.